By Andrew M. Seaman
(Reuters Health) - Health news stories often use overly optimistic terms to describe new cancer drugs, according to a new study.
Read Whole Story
A new drug called T-DM1 appears to be relatively effective and safe for women with metastatic, Her2+ breast cancer, in itself and as compared to the standard XL regimen.
Cancer patients have seen their tumours blasted into submission by a new drug which harnesses the power of their own immune cells.
The 'serial killer...
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.